Table 1. Characteristics of modules used in EQA of dengue diagnostics, WHO Western Pacific Region, 2013.
| Module | Sample ID | Contents | Serotype | Antibodies |
|---|---|---|---|---|
| Viral RNA/NS1 antigen (Module A) | A2013-V01 | Inactivated dengue virus in serum | DENV-2 | – |
| A2013-V02 | Serum alone | Not applicable | – | |
| A2013-V03 | Inactivated dengue virus in serum | DENV-1 | – | |
| Antibody (Module B) | B2013-S01* | Convalescent serum | – | IgM, IgG |
| B2013-S02* | Convalescent serum | – | IgM, IgG | |
| B2013-S03 | Negative human serum | – | Negative control |
* B2013-S01 and B2013-S02 were the same sample collected from a recently recovered dengue patient used to assess the reproducibility of laboratory results.